USD 0.0
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 100.0% |
2015 | -18.4 Thousand USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 468.00 USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 100.0% |
2006 | -849.56 Thousand USD | 28.61% |
2005 | -1.19 Million USD | -92.13% |
2004 | -619.42 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 FY | - USD | 100.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q1 | - USD | 100.0% |
2015 Q4 | -18.4 Thousand USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 FY | -18.4 Thousand USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | -100.0% |
2010 Q1 | - USD | 100.0% |
2010 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2009 Q2 | 2200.00 USD | 0.0% |
2009 Q3 | 5000.00 USD | 127.27% |
2009 FY | 468.00 USD | 0.0% |
2009 Q4 | -6732.00 USD | -234.64% |
2009 Q1 | - USD | 0.0% |
2008 Q1 | - USD | 100.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2007 Q2 | -507.19 Thousand USD | -97.81% |
2007 Q4 | -1.38 Million USD | -358.99% |
2007 FY | - USD | 100.0% |
2007 Q1 | -256.41 Thousand USD | -114.37% |
2007 Q3 | -302.31 Thousand USD | 40.39% |
2006 FY | -849.56 Thousand USD | 28.61% |
2006 Q4 | -119.61 Thousand USD | 37.0% |
2006 Q3 | -189.84 Thousand USD | 5.1% |
2006 Q2 | -200.04 Thousand USD | 41.17% |
2006 Q1 | -340.06 Thousand USD | -30.13% |
2005 Q2 | -345.98 Thousand USD | -45.27% |
2005 FY | -1.19 Million USD | -92.13% |
2005 Q1 | -238.17 Thousand USD | 0.0% |
2005 Q4 | -261.32 Thousand USD | 21.82% |
2005 Q3 | -334.25 Thousand USD | 3.39% |
2004 FY | -619.42 Thousand USD | 0.0% |
2004 Q4 | - USD | 100.0% |
2004 Q2 | -225.38 Thousand USD | 0.0% |
2004 Q3 | -135.49 Thousand USD | 39.88% |
2004 Q1 | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Medical Technologies Inc. | 1.69 Million USD | 100.0% |
Ansell Limited | 624.8 Million USD | 100.0% |
Ansell Limited | 624.8 Million USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 113.94 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | 135.05 Thousand USD | 100.0% |
Psykey, Inc. | 415.97 Thousand USD | 100.0% |
ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
ConvaTec Group Plc | 1.17 Billion USD | 100.0% |
Encision Inc. | 3.13 Million USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | - USD | NaN% |
Innovative MedTech Inc. | 794.01 Thousand USD | 100.0% |
LifePoint, Inc. | -71.35 Thousand USD | 100.0% |
Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 100.0% |
Paradigm Medical Industries, Inc. | 525 Thousand USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | 603.24 Thousand USD | 100.0% |
Reflect Scientific, Inc. | 596.42 Thousand USD | 100.0% |
SmileDirectClub, Inc. | 275.84 Million USD | 100.0% |
Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 100.0% |
SheerVision, Inc. | 2.17 Million USD | 100.0% |
United Health Products, Inc. | -4857.00 USD | 100.0% |
Vasamed, Inc. | -69.38 Thousand USD | 100.0% |
Wearable Health Solutions, Inc. | 267.66 Thousand USD | 100.0% |
Yubo International Biotech Limited | 52.65 Thousand USD | 100.0% |